$EURK

Eureka Acquisition Corp (EURK): Entry into a Material Definitive Agreement

Eureka Acquisition Corp (EURK) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-3.1 2 ea029661301ex3-1.htm FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION, DATED JUNE 29, 2026 Exhibit 3.1 COMPANIES ACT (REVISED) COMPANY LIMITED BY SHARES FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF EUREKA ACQUISITION CORP ADOPTE

Original reporting
Published Jul 6, 2026, 8:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$EURK
Neutral
low confidence
Mentioned
$EURK
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EURKNeutralMed
01

Why it matters

This type of disclosure can affect redemption expectations, deal certainty, and near-term liquidity/volatility, but the excerpt does not include the agreement terms or vote results.

02

Market read

Event-driven catalyst: a material definitive agreement plus a security-holder vote can change deal probability and redemption dynamics, but direction requires the missing agreement details.

03

What to watch

Traders should verify the full 8-K exhibits (not included here) for: deal counterparties, consideration structure, redemption mechanics, termination fees, and voting thresholds—these drive whether the news is bullish or dilutive.

Relevance 6/10Novelty 5/10Timing: Filed today (2026-07-06) after-hours; relevant for positioning ahead of the security-holder vote timeline.

Background

The filing is an SEC Form 8-K with Item 1.01 (entry into a material definitive agreement) and Item 5.07 (matters submitted to a vote of security holders).

Company-level read

Ticker impact

$EURKNeutralLow confidence
Context

EURK filed an 8-K stating it entered a material definitive agreement and submitted matters to a security-holder vote.

Expected impact

Near-term volatility possible around the referenced definitive agreement and the security-holder vote; direction depends on deal terms not included in the excerpt.

Evidence & confidence

The excerpt confirms an 8-K item (material definitive agreement) but does not provide the agreement’s economic terms, counterparties, or vote outcomes, limiting conviction on direction and magnitude.

Market effects

Limited—this is company-specific SPAC/transaction governance disclosure with no sector-wide datapoints in the excerpt.

Limited—no regional macro or cross-border operational impacts described.

Low—no global counterparties, regulatory actions, or cross-market effects are disclosed in the provided text.

Counterpoint

Because the excerpt lacks the definitive agreement’s terms, the market may already be pricing the event; the incremental impact could be small unless the full exhibit reveals material economics.

Key entities

  • Eureka Acquisition Corp

    SPAC/blank-check company filing the 8-K for entry into a material definitive agreement and a security-holder vote.

Related articles

$MPLTMedAI 8/10

MapLight Raises $150 M PIPE To Fund CNS Pipeline

MapLight Therapeutics (MPLT) priced a $150 million PIPE, selling 9.2M shares at $11.38 and 4.0M pre-funded warrants at $11.3799, exercisable at $0.0001 with no expiration. Proceeds will fund CNS drug ML-007C-MA, including VISTA Phase 2 in Alzheimer’s disease psychosis and ZEPHYR-2 Phase 3 in schizophrenia. Closing expected Aug. 14, 2026.

$TSNMedAI 8/10

Tyson Foods will close or sell three US beef facilities as industry struggles

Tyson Foods said it will close or sell three US beef facilities, ending operations at Joslin, Illinois and Eagle Mountain, Utah, and pursuing the sale of Pasco, Washington, while shifting capacity to other sites. The move follows prior Tyson beef shutdowns and comes as a 75-year cattle supply trough drives losses. Tyson forecast a $500m to $650m adjusted beef operating loss for fiscal 2026.

$MVISMedAI 8/10

MicroVision, Inc.: MicroVision Announces Launch of Proposed Public Offering

MicroVision (NASDAQ:MVIS) said it has commenced a proposed public offering of units, each unit consisting of one share of common stock (or a pre-funded warrant in lieu) and one warrant to buy one share. MicroVision will sell the shares and warrants, with final terms to be set at pricing. Net proceeds are for general corporate purposes, including working capital and capex.

$ORCLMed

Oracle planning new round of layoffs in August 2026

Oracle plans another layoff round in August 2026, according to Business Insider citing internal documents and people familiar with the plans. It says some teams could face double-digit cuts, with managers asked to identify affected employees ahead of Sept. 1. Oracle previously cut 21,000 jobs and recorded $1.8B restructuring charges. Oracle is funding AI data centers with large debt and equity.

$TSNMed

Tyson Foods to close 2 facilities, pursue sale of another amid 'historic' cattle shortage

Tyson Foods said it will close its Joslin, Illinois beef plant and its Eagle Mountain, Utah case-ready facility, and is pursuing the sale of its Pasco, Washington beef facility, citing strategic changes to its beef network amid a “historic” cattle shortage. Tyson plans to shift capacity to Dakota City, Nebraska; Holcomb, Kansas; and Amarillo, Texas, and ramp a second shift in Amarillo, according to the company.

$KPTIHighAI 9/10

It's crunch time for Karyopharm as company faces potential default next month

Karyopharm Therapeutics reported Q2 results showing a $67 million loss and cash reserves of $65.4 million. A $15.8 million loan payment is due Sept. 10, and without financing or a waiver the company says it would breach a $10.0 million liquidity covenant and could default. It is negotiating with lenders and pursuing Xpovio label expansion; Q2 Xpovio sales were $30.8 million.